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1. Introduction
  Reactive oxygen species (ROS), plays important role in the 
production of tissue injury through covalent binding and 
lipid peroxidation and can augment fibrosis as seen from 
increased collagen synthesis[1]. Scavenging of free radicals 
by antioxidants could reduce the fibrosis process in the 
tissue[2]. Recently, clinical importance of herbal drugs has 
received considerable attention. Free radicals may also 
contributory factor in the function of the immune system[3]. 
Several medicinal plants have been screened based on the 
integrative approaches on drug development against liver 
diseases[4]. Even though, studies related with the scientific 
evaluation of the mangrove plants against liver diseases are 
too restricted. In this regard, the present study was made an 
attempt to investigate the hepatoprotective and antioxidant 
property of the Luminetzera racemosa(L. racemosa) bark 
extract against carbon tetrachloride induced hepatotoxicity 
in Wistar albino rats. 
2. Materials and methods
2.1.Collection and preparation of extracts
  The bark samples of L. racemosa were collected during the 
spring season from Pichavaram mangrove forest (Lat. 11° 
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20’ N; Long. 79° 47’ E), Tamil Nadu, India. The specimen 
sample was authenticated by Prof. Kathiresan K, Centre of 
Advanced Study in Marine Biology, Annamalai University, 
Porto Novo, Tamil Nadu, India. The voucher specimen 
(AUOCAS033 and AUOCAS034) was also maintained in the 
herbarium cabinet facility, sponsored by Indian Council of 
Medical Research, New Delhi at School of Marine Sciences, 
Department of Oceanography and Coastal Area Studies, 
Alagappa University, Thondi Campus, Thondi, India. The 
collected parts were washed thrice with distilled water to 
remove the contaminants and air dried in shade. Coarsely 
powdered sample (500 g) was defatted with petroleum ether 
(60-80 曟) and then extracted with 1 L of 95% (V/V) ethanol 
and water mixture by percolation method. The extract was 
concentrated under vacuum to the solvent free residues. 
Preliminary phytochemical analysis such as phenolic group, 
alkaloids, flavonoids, catachin, triterpenoids, tannins, and 
anthroquinones were calculated by the standard protocols[5].
2.2. Carbon- tetrachloride induced hepatotoxicity 
  Male Wistar albino rats (150-200 g) were divided into nine 
groups consisting of 6 animals per group. Group 1 (Control) 
received three doses of 5% acacia mucilage (1 mL/kg bw 
po.) with 12 hrs intervals (0 hr, 12 hrs and 24 hrs). Group 
2 (Hepatotoxin group) received three doses of vehicle [5% 
acacia mucilage (1 mL/kg bw po.)] at 12 hrs intervals and a 
single dose of carbon tetrachloride (2 mL/kg bw ip.) diluted 
in liquid paraffin (1:1) 30 min after the administration of first 
dose of vehicle.  Group 3 (Positive control) received three 
doses of silymarin (100 mg/kg bw po.) at 0 hr, 12hrs and 24 
hrs intervals. Carbon tetrachloride diluted in liquid paraffin 
(1:1) (2 mL/kg bw ip.) was administrated 30 min after the 
administration of first dose of silymarin. Group 4, 5 and 6 
(Treatment groups) received with different doses of (100, 
200 and 300 mg/kg bw po.) L. racemosa bark extract at 0 hr, 
12 hrs and 24 hrs intervals. Carbon tetrachloride diluted in 
liquid paraffin (1:1) (2 mL/kg bw ip.) was administrated 30 min
after the administration of first dose of bark extract. All 
the animal model studies and experimental protocols have 
been approved by Institutional Animal Ethics Committee, 
Alagappa University, Tamil Nadu, India. 
2.3. Liver function test
  After 36 h of administration of CCl4, all the animals were 
anesthetized with mild ether and blood samples were 
collected by eye bleeding method. The collected blood 
was allowed to clot at room temperature and serum was 
separated by centrifugation at 2 500 rpm for 10 min. The 
serum was used for the estimation of biochemical parameters 
to determine the functional state of liver. Serum glutamic 
oxaloacetic transaminase (SGOT), serum glutamic pyruvic 
transaminase (SGPT), lactate dehydrogenase (LDH) and 
alkaline phosphatase (ALP) were assayed by following the 
method of Vidya et al(2007)[6]. Total protein and albumin[7], 
sugar[8], cholesterol[9] and bilurubin[10] were assayed using 
randox laboratory kits. 
2.4. Analysis of histopathological scores
  Animal from each group were sacrificed and the abdomen 
was cut open to remove the liver. Then the liver was fixed in 
bouins solution (mixture of 75 mL of saturated picric acid, 
25 mL of 40% formaldehyde and 5 ml of glacial acetic acid) 
for 12 hrs, then embedded in paraffin using conventional 
methods and cut into 5 毺m thick sections and stained using 
haematoxylin-eosin dye and finally mounted in di-phenyl 
xylene[11]. The section was observed under microscope 
for any histopathological changes. The liver pathology 
was scored as described by Jamshidzadeh[12]. Histological 
damage was expressed using the following score system: 
0= no visible cell damage; 1= focal hepatocytes damage on 
<25%-50% of the tissue; 3=extensive, but focal hepatocytes 
lesion; 4= global hepatocytes necrosis.
2.5. In vitro antioxidant assay 
  In vitro antioxidant assays such as DPPH scavenging 
and  nitric oxide radical scavenging[13], hydroxyl radical 
scavenging[14], lipid peroxide radical scavenging, ferric 
reducing antioxidant(FRAP) and superoxide radical 
scavenging[15] were calculated with different concentrations 
(1.9 毺g/mL to 500 毺g/mL) of L. racemosa bark extract and 
vitamin C (Positive control). Statistical calculations such 
as IC50 values and SD values calculated with office XP/SDAS 
add-ins program.
3. Results
  The results of the present study suggested that, the level 
of SGOT [(313.5依16.53 )IU/L], SGPT [(232.65依17.38) IU/L], 
ALP [(956.36依64.72) IU/L], bilurubin [(3.12依0.48) mg/dL], 
cholesterol [(243.45依15.43) mg/dL], sugar [(162.66依7.65) mg/dL]
and LDH [(2 785.00依236.50) IU/L] were significantly (P<0.05) 
increased in hepatotoxin treatment (Group 2), but the 
content of total protein [(3.48依0.47) g/dL] and albumin [(1.27
依0.46) g/dL] were significantly (P<0.05) found less when 
compared with the control group (Group 1). But, different 
concentration of (75, 150 and 300 mg/kg bw) bark extract 
treated rats showed significant (P<0.05) reduction in the 
elevated level but, the maximum reduction of SGOT [(225.36
依13.65) IU/L], SGPT [(96.85依17.36) IU/L], ALP [(315.37依17.16) 
IU/L], bilirubin [(2.97依0.46) mg/dL], cholesterol [(163.73依
17.54) mg/dL], sugar [(127.35依27.35) mg/dL] and LDH [(1 
784.00依±268.36) IU/L] were observed with the high dose 
extract treated rats (Table 1). Histopathological scores 
revealed that, the maximum level of fatty changes (3), focal 
necrosis (3), congestion in central vein (3) and congestion 
in sinusoidal spaces (2) were found in hepatotoxin treated 
rats. However, L. racemosa bark extract (75 mg/kg bw 
and 150 mg/kg bw) treated rats showed reduction in fatty 
changes, focal necrosis, hydrophic changes, and no visible 
changes were observed with high dose (300 mg/kg bw) of 
bark extract treated rats except mild fatty changes when 
compared with the hepatotoxin treated groups (Figure 1). 
The in vitro antioxidant assays showed that, the IC50 values 
were observed as (44.17依6.87) 毺g/mL, (42.45依2.81) 毺g/mL, 
(62.37依3.98) 毺g/mL, (54.24依3.09) 毺g/mL, (87.25依5.90) 毺g/mL
and (71.54依5.42) 毺g/mL for DPPH, hydroxyl radical 
scavenging activity (HRSA), NO, FRAP, lipid hydroperoxide 
(LPO) and super oxide dismutase (SOD) radical scavenging 
activities, respectively, and the results are comparable 
with the positive control of the vitamin C (Table 2). The 
preliminary phytochemical analysis of the bark extract 
showed the presence of reducing sugars, protein, phenolic 
groups, alkaloids, triterpenoids and tannins. However, the 
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steroids and anthroquinone were not observed with the bark 
extract.
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Figure 1. Liver sections stained with haematoxylin and eosin (40伊). 
 (A) Control group; (B) CCl4 treated rats; (C) Silymarin treated rats (100 
mg.kg-1.bw); (D) 100 mg.kg-1.bw of L. racemosa bark extract treated 
rats (E) 200 mg.kg-1.bw L. racemosa bark extract treated rats (F) 
300 mg.kg-1.bw of L. racemosa bark extract treated rats. CV: Central 
vein; S: Sinusoids; H: Hepatocytes; N: Necrosis, F: Fatty changes; V: 
Vacuoles; CS: Congestion in sinusoidal spaces; CCV: Congestion in 
central vein; PV: Portal vein D: hepatic deformities.
4. Discussion
  World health organization survey indicates that, a total 
of about 70%-80% of the world’s population rely on, 
non commercial medicine mainly the herbal sources, in 
the primary health care units[16]. Although, plants and 
plant materials play several important roles in biological 
and pharmacological activities in humans as well as in 
animals[17]. In this connection, one such marine plant part 
of the L. racemosa bark extract was selected for in vivo 
hepatoprotective activity against CCL4 induced hepatotoxicity 
in Wistar albino rats. The result of the present studies 
suggest that, the hepatotoxic effect of CCL4 is due to the 
conversion by the cytochrome- p450 mixed function enzyme 
in the smooth endoplasmic reticulum of the liver and other 
organs to the highly reactive CCL3 molecules[18]. Highly 
reactive tricoloro free radicals formation directly attacks the 
poly unsaturated fatty acids of the endoplasmic reticulum 
and thus causes over production of SGOT, SGPT, ALP, bilirubin 
and LDH enzymes[19]. Pre-treatment of L. racemosa bark 
extract showed the antagonizes activity against the elevated 
enzyme parameters. Reduction in the level of SGOT, LDH 
and SGOT enzymes towards the normal value is an indication 
of the hepatic cell regeneration process[18]. Reduction in the 
level of ALP with the concurrent depletion with the raised 
bilirubin level suggest the stability of the biliary function. 
In CCL4 intoxicated rats the level of total protein and 
albumin were significantly reduced this might be due to the 
functional failure of the cytochrome p450 complexes[18]. But, 
L. racemosa bark extract treated rats showed raised level of 
total protein and albumin concentration, this might be due 
to the stabilization of endoplasmic reticulum[20]. Suppression 
of the cholesterol level by the extracts suggests the bile 
acids synthesis inhibition was reversed[21]. The protective 
Table 1
Effect of L. racemosa bark extract on the biochemical parameters in CCl4 induced hepatotoxicity in rats
Parameters Control
Hepatotoxin 
group(CCl4)
Silymarin positive 
control
L. racemosa bark extract (mg/kg bw)
100 200 300
SGOT(IU/L)   167.33依13.27    313.5依16.53* 181.85依8.63#      304.4依18.28#  261.43依32.29# 225.36依13.65#
SGPT(IU/L)   60.67依5.39  232.65依17.38*   84.13依6.37#    204.02依21.12#  194.54依17.31#   96.85依17.36#
ALP(IU/L) 135.27依9.67  956.36依64.72*      192.85依10.26#    671.26依118.12#  490.23依64.14#  315.37依17.16#
BIL(mg/dL)     1.28依0.13    3.12依0.48*     1.46依0.19#        2.97依0.87#    2.26依0.44#    2.97依0.46#
CHL(mg/dL)   90.39依7.69   243.45依15.43* 110.55依6.88#    217.64依21.36# 181.32依6.24#  163.73依17.54#
SUG(mg/dL)     85.66依10.34 162.66依7.65*  101.36依7.63#    172.32依8.39 148.00依4.54#  127.35依27.35#
LDH(U/L)     886.00依137.65 2 785.00依236.50* 1 842.00依31.00# 2 621.46依175.47# 2 041.01依158.06# 1 784.00依268.36#
TPN (g/dL)     8.68依1.03    3.08依0.87*      5.97依0.81#        4.43依1.96#    5.72依0.25#    6.95依0.26#
ALB (g/dL)     4.38依0.84    1.87依0.64*      3.01依0.38#        2.36依0.49#    3.02依0.93#    4.00依0.84#
BIL: bilurubin, CHL: cholesterol, SUG: sugar; * P<0.05 vs. control, #P<0.05 vs. CCl4 -treated rats. 
Table 2 
IC50 values of L. racemosa bark extract and vitamin C with various antioxidant activities (毺g/mL).
Parameter L. racemosa bark extract Vitamin C
DPPH 44.17依6.87   2.87依1.26
HRSA 42.45依2.81 44.24依1.50
NO 62.37依3.98   4.98依1.28
FRAP 54.24依3.09 56.69依1.11
LPO 87.25依5.90 31.79依1.21
SOD 71.54依5.42 24.31依0.71
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effect exhibited by the high dose (300 mg/kg bw) of L. 
racemosa bark extract was comparable with the standard 
drug silymarin (100 mg/kg bw). The histopathological 
examination of the liver sections confirmed that, normal 
liver cellular architecture was damaged with CCL4 treated 
rats. However, the liver sections from bark extract treated 
rats showed that, the reduction in histopathological scores 
as well as cellular damage and thus further, confirming 
the hepatoprotective effect of the L. racemosa bark 
extract[22]. Moreover, in biological systems lipid bi-layers 
of the cellular membrane are potential target site for the 
free radicals and this oxidants plays several pathological 
conditions including aging, hepatotoxicity, cancer and 
inflammation. The in vitro antioxidant studies revealed such 
as DPPH, superoxide radical scavenging, hydroxyl radical 
scavenging and lipid peroxide radical scavenging activity of 
the L. racemosa bark extract and thus suggest the ability of 
the good antioxidant activities[14,23,24]. The hepatoprotective 
and antioxidant activity of the bark extract might be due to 
the presence of unique phytochemical constituents such 
as flavonoids, alkaloids[25] and polyphenols[26] and its free 
radical scavenging activities. In conclusion, the present 
studies demonstrated that, pre administration of the L. 
racemosa bark extract could provide good hepatoprotective 
activity against CCL4 intoxication in Wistar albino rats and 
could be used as an herbal medicine for the treatment of 
liver damage after completing the successful clinical trials.   
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